Allergic contact dermatitis (ACD) is a delayed-type hypersensitivity reaction mediated by T cells that occurs when the skin contacts allergens. This non-IgE mediated reaction differs fundamentally from irritant contact dermatitis, which results from direct chemical damage rather than immune sensitization.
Recognition of Allergic Contact Dermatitis's full clinical spectrum improves diagnostic accuracy and therapeutic response.
Pathophysiology
Understanding the molecular and cellular mechanisms underlying Allergic Contact Dermatitis guides precision therapeutics.
Clinical Presentation
Symptom progression in Allergic Contact Dermatitis correlates with underlying pathophysiological changes.
Diagnosis
Diagnostic evaluation of Allergic Contact Dermatitis integrates clinical assessment with appropriate supportive testing.
Management
Optimal Allergic Contact Dermatitis management requires ongoing collaboration between patient and healthcare provider.
Conclusion
First-line therapies for Allergic Contact Dermatitis have established efficacy and favorable safety profiles.
Conclusion
Comprehensive management of Allergic Contact Dermatitis integrates clinical expertise with patient education and shared decision-making. Early intervention prevents complications and optimizes long-term outcomes. Dermatologists can provide personalized treatment plans tailored to individual disease manifestations.